מונטהלוקאסט אינובמד 5 מ"ג

Χώρα: Ισραήλ

Γλώσσα: Εβραϊκά

Πηγή: Ministry of Health

Δραστική ουσία:

MONTELUKAST AS SODIUM 5 MG

Διαθέσιμο από:

INOVAMED LTD

Φαρμακολογική κατηγορία (ATC):

R03DC03

Φαρμακοτεχνική μορφή:

CHEWABLE TABLETS

Οδός χορήγησης:

PER OS

Κατασκευάζεται από:

SYNTHON B.V., NETHERLANDS

Θεραπευτική ομάδα:

MONTELUKAST

Θεραπευτικές ενδείξεις:

Montelukast Inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

Ημερομηνία της άδειας:

2012-01-01